Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2007
10/24/2007CN101057876A Patrinias cabra aglycon extraction and its preparation method and anti colon cancer application
10/24/2007CN101057872A Anti tumor active part of American cockroach prepared with reverse phase material and medical application
10/24/2007CN101057842A Application of C60-benzoic acid nitrogen mustard in preparing medicine for anti tumor
10/24/2007CN101057836A Application of honokiol in preparing medicine for treating acute leukemia
10/24/2007CN101057831A Docetaxel liposome novel preparations and its preparation method
10/24/2007CN101057693A Double embryo beverage
10/24/2007CN101057616A Recuperating tea
10/24/2007CN100344970C Treatment and diagnosis of cancer
10/24/2007CN100344747C Sulfated NF1 granulose-anti-AIDS medicine and its preparing method
10/24/2007CN100344646C Oligonucleotide-containing pharmacological compositions and their use
10/24/2007CN100344637C Synthetic method for organic germanium naphthol ester and organic germanuim anthraquinone amide compound
10/24/2007CN100344627C Epothilones C, and its preparation and use as cell inhibitor
10/24/2007CN100344605C Preparation method of 3-fluoro-5-nitro trifluor toluene
10/24/2007CN100344325C Medicine for treating cervical carcinoma, its preparation process and application
10/24/2007CN100344295C Ganoderma lucidum capsule of lycopene
10/24/2007CN100344288C Compound pain-stopping and inflammation-diminishing anticarcinogen capsule
10/24/2007CN100344287C Biodegradable polyester fluorouracil microglobule and its preparation method
10/24/2007CN100344278C Lasofoxifene tablet and its coating
10/24/2007CN100344277C Nano-magnetic medicinal microglobule, its preparation method and application
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285668 At a concentration of 0.1-0.5 g/ml. at 0-35 degrees C. from a C1-4 alkyl acetate solution; preservation stability
10/23/2007US7285664 Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
10/23/2007US7285649 Immunoglobulin; for use in diagnosis and treatment of cancer; antitumor agents; anticarcinogenic agents
10/23/2007US7285642 Composition and method for modulating dendritic cell-T cell interaction
10/23/2007US7285635 Reducing the antigenicity of a proteinaceous compound while maintaining the compound's biological activity
10/23/2007US7285630 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor
10/23/2007US7285622 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides
10/23/2007US7285572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis
10/23/2007US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007US7285556 Antiproliferative agents; hematologic, nervous system, autoimmune diseases; osteoporosis, viral infections
10/23/2007US7285555 Promoting microtube polymerization; drug resistanct cancer
10/23/2007US7285549 Sulfamides and their use as endothelin receptor antagonists
10/23/2007US7285546 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents
10/23/2007US7285535 Administering TIRAP to block Toll/Interleukin-1 Receptor Adaptor Protein signaling in a cell; for treatment of inflammation and inducing or affecting immune response.
10/23/2007US7285527 Tumor radiosensitization using gene therapy
10/23/2007US7285382 Compositions and methods for treatment of cancer
10/23/2007US7285293 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein
10/23/2007US7285282 Mucin peptide with immunoenhancing properties
10/23/2007US7285281 Genetically engineered toxin comprising a-subunit of wildtype cholera toxin for treatment and prevention of infections, cell proliferative, nervous system and metabolic disorders
10/23/2007US7285279 Method of treating malignancies and viral infections and improving immune function with a dietary supplement
10/23/2007CA2384433C Novel betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
10/23/2007CA2263889C P-selectin ligand proteins
10/23/2007CA2217780C Polyether nucleic acids
10/23/2007CA2206179C Vectors for tissue-specific replication
10/20/2007CA2541903A1 A method of diagnosis and treatment
10/18/2007WO2007118249A2 Personal electronic device carrier
10/18/2007WO2007118214A2 Antibody compositions and methods for treatment of neoplastic disease
10/18/2007WO2007118198A2 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF
10/18/2007WO2007117995A2 Kinase inhibitors
10/18/2007WO2007117692A2 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
10/18/2007WO2007117577A2 High affinity human antibodies to human il-18 receptor
10/18/2007WO2007117563A2 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof
10/18/2007WO2007117472A2 Adult bone marrow cell transplantation to testes creation of transdifferentiated testes germ cells, leydig cells and sertoli cells
10/18/2007WO2007117398A2 Non-peptidic molecules for detecting and treating tumors
10/18/2007WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof
10/18/2007WO2007117038A1 Prophylactic/therapeutic agent for cancer
10/18/2007WO2007117022A1 Chewing composition comprising coenzyme q10
10/18/2007WO2007116808A1 Virus particle-like structure and pharmaceutical preparation comprising the same
10/18/2007WO2007116432A1 Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pharmaceutical, cosmetic and food comprising the same
10/18/2007WO2007116396A1 Treatment of hematological malignancies with fts and a bcr-abl tyrosine kinase inhibitor
10/18/2007WO2007116135A1 Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
10/18/2007WO2007116029A2 Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor
10/18/2007WO2007116025A2 Use of c-src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia
10/18/2007WO2007115931A1 Thiazolyldihydrocyclopentapyrazoles for use as pi3-kinase inhibitors
10/18/2007WO2007115829A2 Anti ku70 internalizing antibodies
10/18/2007WO2007115822A1 Thienopyrimidines having mnkl /mnk2 inhibiting activity for pharmaceutical compositions
10/18/2007WO2007115820A1 Chromen-2-one derivatives
10/18/2007WO2007115813A1 Glycosylated antibodies
10/18/2007WO2007115670A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases
10/18/2007WO2007115620A2 Novel cyclobutyl compounds as kinase inhibitors
10/18/2007WO2007115473A1 Pyrrole derivatives inhibitors, their curative uses
10/18/2007WO2007115430A1 Formulation of unsaturated salt of ampelopsin and its application
10/18/2007WO2007115414A1 Modified h2 relaxin for tumor suppression
10/18/2007WO2007097470A3 Fused nitrogen- comprising heterocyclic compound
10/18/2007WO2007092721A3 Vitamin d analog: rak, methods and uses thereof
10/18/2007WO2007092720A3 Vitamin d analog: nel, methods and uses thereof
10/18/2007WO2007087580A3 Y134.5 deficient hsv comprising a coding region of a member of the mapk pathway for the treatment of a cell proliferation disorder
10/18/2007WO2007084415A3 Compounds for the treatment of inflammatory disorders
10/18/2007WO2007082104A3 Compounds and methods for the treatment of cancer
10/18/2007WO2007076473A3 Substituted pyrimidinyloxy ureas useful as inhibitors of protein kinases
10/18/2007WO2007064345A3 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
10/18/2007WO2003061560A3 Replication competent dual-ad vectors for vaccine and immunotherapy applications
10/18/2007US20070244186 cdc25 tyrosine phosphatase inhibitors such as 5-{[2-(dimethylamino)ethyl]amino}-2-(morpholin-4-ylcarbonyl)-1,3-benzothiazole-4,7-dione, used as anticarcinogenic agents
10/18/2007US20070244161 Novel mercaptophenyl naphthyl methane compounds and synthesis thereof
10/18/2007US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase
10/18/2007US20070244136 Quinazoline Derivatives
10/18/2007US20070244133 Thienopyrimidines and Thiazolopyrimidines for Use in Medicine
10/18/2007US20070244132 Fused Heterocyclic Compound
10/18/2007US20070244124 For therapy of multi-drug resistant disease; combination therapy; anticarcinogenic agent; leukemia; hydrochloride salt; obtained with copper radiation source
10/18/2007US20070244123 Heterocycle-carboxamide derivatives as raf kinase inhibitors
10/18/2007US20070244112 Novel tetrahydropyridothiophenes
10/18/2007US20070244083 Using fluorouracil and/or oxaliplatin as diagnostic tools in detection of SCN1A-T1067A-SNP genetic polymorphism in the preferential and diagnosis of colorectal cancer
10/18/2007US20070244082 Anticancer Agent
10/18/2007US20070244065 Composition Comprising a Survivin Oligonucleotide and Gemcitabine for The Treatment of Cancer
10/18/2007US20070244063 Inducing angiogenesis comprising contacting endothelial cells expressing Bv8 receptor with a polypeptide comprising the amino acid sequence of SEQ ID NO:2; using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival; screening for Bv8 modulators
10/18/2007US20070244047 Albumin fusion proteins
10/18/2007US20070244030 Method for Assessing Cancerous State
10/18/2007US20070243612 Novel Compounds for Modulating Cell Proliferation
10/18/2007US20070243609 Cell populations which co-express CD49c and CD90
10/18/2007US20070243588 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
1 ... 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 ... 2211